Science News
from research organizations

Fecal transplants show promise, but need careful monitoring, say experts

Date:
October 20, 2015
Source:
BMJ
Summary:
The use of fecal transplants to treat severe infections has rapidly become the treatment of choice, but as use increases and widens proper screening of donors, and good long term trials and monitoring are urgently needed in order to provide sensible advice to patients, say experts.
Share:
FULL STORY

The use of fecal transplants to treat severe infections has rapidly become the treatment of choice, but as use increases and widens proper screening of donors, and good long term trials and monitoring are urgently needed in order to provide sensible advice to patients, say experts in The BMJ today.

Gut microbes play a key role in our immune systems and health -- and transplanting fecal matter from one person to another is increasingly being used to control severe life-threatening infections like recurrent Clostridium difficile that kill thousands of people annually.

The procedure involves introducing a liquidised stool (or frozen microbes) from a healthy donor to the bowel of a patient to re-colonise their gut with healthy bacteria, which are often destroyed after prolonged antibiotic treatment.

An analysis of the evidence found an 85% success rate with fecal transplants compared with only 20% success for standard antibiotic treatment. And a recent trial was stopped early because of the overwhelming superiority of fecal transplantation, with 90% success rate compared with 26% for powerful antibiotics.

So far, after over 7000 transplants, few adverse effects are being reported, and despite early fears, transplants even seem relatively safe in elderly patients or those with an impaired immune system, say Professor Tim Spector from King's College London and Professor Rob Knight from the University of California San Diego.

Over 500 US centres now offer fecal transplantation, most supplied from a single lab in Boston, and the use of fecal transplantation for C difficile infection has now been cautiously endorsed by the American Academy of Gastroenterology and European Society of Microbiology and Infectious Diseases.

While European and Australian regulators are stalling, the UK regulator (MRHA) has temporarily classed fecal transplants as a medicinal product (with exemptions from many of the usual regulatory barriers) and the procedure has been approved by NICE. But in contrast to the US, the UK now has only around seven centres that offer the treatment.

While "it is clearly better than further antibiotics for treating conditions like C difficile," the use of fecal transplantation is being increasingly tested in other common conditions, including obesity, diabetes, irritable bowel syndrome, colitis and many others. However, claims that fecal transplantation could be a cure-all for many diseases, "are probably too optimistic," say Spector and Knight.

As well as the obvious risks of infection (reduced by screening), there are longer term potential risks of transferring microbes to a new host, which could include transferring susceptibility to obesity and even mental illness, they write. "These possible risks suggest that fecal transplantation, although an exciting new tool, should be carefully monitored and refined to include most of the key beneficial microbes."

"We urgently need more expertise and centres, proper screening of donors, and good long term trials and monitoring procedures in order to provide sensible advice," they conclude. Otherwise, patients with many chronic complaints "may lose patience and take matters into their own hands (using DIY methods) with unpredictable consequences."


Story Source:

Materials provided by BMJ. Note: Content may be edited for style and length.


Journal Reference:

  1. Tim Spector, Rob Knight. Faecal transplants. BMJ, 2015; h5149 DOI: 10.1136/bmj.h5149

Cite This Page:

BMJ. "Fecal transplants show promise, but need careful monitoring, say experts." ScienceDaily. ScienceDaily, 20 October 2015. <www.sciencedaily.com/releases/2015/10/151020191706.htm>.
BMJ. (2015, October 20). Fecal transplants show promise, but need careful monitoring, say experts. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2015/10/151020191706.htm
BMJ. "Fecal transplants show promise, but need careful monitoring, say experts." ScienceDaily. www.sciencedaily.com/releases/2015/10/151020191706.htm (accessed May 23, 2017).

RELATED STORIES